disease

Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s disease and other movement…

Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…

Summary : BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year from Renuka Ramnath-led private equity (PE) fund…

Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…

Summary : British biotech company Scancell has expanded its research and development capabilities at one of the UK’s leading parks for science…

Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will…

Synopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental maternal vaccine for respiratory syncytial virus (RSV).…

Summary : The DTAB has approved a list of OTC drugs which includes medicines like antifungal infections, analgesics (pain killers), cough syrups,…

Summary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…

Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…